The business model to whether it is going to be in diagnostics or testing is the same business decisions that we make in our home. It is simply about risk and reward.
Editor's note · Context
Shimkus discusses the importance of balancing risk and reward in diagnostics and testing.
Share & report
More from John Shimkus
Mr. Speaker, I rise with concerns about the troubling pattern of legislating national chemical policy based upon emotions rather than scientific fact, including in this NDAA. I am referring specifically to certain anti-science…
I have said it before, but I believe it bears repeating we need to not only know how Americans' tax dollars are being spent, but are Americans' getting a better quality of life for their return on investment.
It is no surprise that we have the law of the land for failure of the appropriators to spend the money.
Madam Speaker, I rise in opposition to the amendment. The SPEAKER pro tempore. The gentleman from Illinois is recognized for 5 minutes.





